HALISTER: Chugai Says Baxalta Filed Lawsuit on Hemophilia Drug Patent

Chugai Says Baxalta Filed Lawsuit on Hemophilia Drug Patent

(Bloomberg) -- Baxalta files suit in Tokyo district court alleging that Chugai’s development of emicizumab for hemophilia A infringes on one of its patents, Chugai says in a statement
  • Baxalta seeks injunction against manufacture, usage, export of the experimental medicine even for clinical trials
  • Chugai says it’s confident emicizumab does not infringe on the patent and “plans to vigorously pursue” court defense
  • No changes expected to financial prospects for fiscal year 2016: Chugai
Alert: HALISTER
Source: BFW (Bloomberg First Word)

Tickers
BXLT US (Baxalta Inc)
4519 JP (Chugai Pharmaceutical Co Ltd)
ROG VX (Roche Holding AG)

To de-activate this alert, click here

UUID: 7947283